Featured Post from Augusta University

Up in smoke? With vaping on the edge of banishment, let our experts help with your coverage

Jul 7, 2022

4 min

The U.S. Food and Drug Administration (FDA) has paused a ban on the sale of Juul Labs' e-cigarettes, saying an additional review of the company's marketing application is required.


The once thriving company won a temporary reprieve a couple of weeks ago after a federal appeals court stayed the FDA's ban, following an appeal from Juul for an emergency review of the regulator's order.



Juul has always been in the spotlight, in part because of its prominent placement atop the e-cigarette chain, but with the company facing a potential demise, it could be the first casualty, with the rest of the vaping industry in the government's sights.


Dr. Zubair Karim, assistant professor in the Department of Interdisciplinary Health Sciences at Augusta University, fields a few questions and lends his expert perspective on this topic.



With the ban on Juul products, could this result in a ban on other companies’ e-cigarette products as well, or was there something specifically about Juul that caused their ban?


This is the first steps toward the banning of the e-cigarette, i.e., Juul, where the FDA took a significant and bold step. Gradually, this will open the path for banning of the other e-cigarette products. There are no differences in the Juul and other products but Juul became more popular in our young generation. Many local and state jurisdictions have recently begun enacting laws that prohibit e-cigarette usage that smoking is banned, although some state laws with comprehensive smoke-free laws will still allow for vaping to be permitted in bars and restaurants while prohibiting e-cigarettes in other indoor places.



On a more basic level, what are platelets (where are they, and what do they do) and do we know what has caused them to react more negatively compared to traditional smoking?


Platelets are small and colorless stem cell fragments present in our blood. They are disk-shaped and don’t have a nucleus. It plays an important role in maintaining vascular integrity based on their ability to respond to lesions in a vessel wall. Hyperactivity of platelets is known to cause spurious clot formation and occlusive loss of blood flow, leading to strokes and heart attacks, whereas hypoactivity causes bleeding diathesis with life-threatening consequences. Several studies have been reported that smoking induces oxidative stress, leading to increased platelet activation, whereas nicotine causes the damage of endothelial lining of the arterial and venous system and ultimately leads to the severe life-threatening consequences.


What are thrombotic events and why should someone be worried about them?


Thrombosis is the formation of a blood clot (partial or complete blockage) within blood vessels, whether venous or arterial, limiting the natural flow of blood. There are several complications depending on where the thrombosis is located. The most serious problems include stroke, heart attack and serious breathing problems, which is called pulmonary embolism. If the patients are not treated in a timely manner, it will lead to life-threatening conditions. However, progression of the disease can be prevented by following changes in our lifestyle such as increasing physical activity, quitting smoking, losing weight, eating a balanced diet, quitting junk food and managing other health conditions.



How do nicotine and other harmful chemical levels compare in vaping vs. traditional cigarettes?


Both smoking and vaping have similar side effects and cause serious health risks in the long run. Scientists do not fully understand the long-term health effects of electronic cigarettes (e-cigarettes), yet science indicates that they are not a safe alternative to smoking. In the last several years it has been observed that vaping is growing in popularity among teenagers. Moreover, e-cigarettes contain a large dose of nicotine, a substance known to slow the development of brains in fetuses, children and teens. Furthermore, vaping involves breathing in aerosol that contains several chemicals, including nicotine and flavoring through an e-cigarette or other devices. Also, the liquid present in the e-cigarettes which creates the vapor is dangerous to adults and children if they swallow, inhale, or get it on the skin. Nonetheless, vaping also delivers dangerous chemicals, including diacetyl, cancer-causing chemicals, heavy metals, volatile organic compounds (VOCs), and such toxic chemicals that are not generated in traditional cigarettes. In summary, long-term vaping causes similar toxic impact to overall health compared to traditional cigarettes.


This court case will be getting a lot of attention and could determine the future of the e-cigarette industry. If you're a journalist looking to know - then let Augusta University's expert help.


Karim is available to speak with reporters about vaping and e-cigarettes. Simply click on his icon now to arrange an interview today.

Powered by

You might also like...

Check out some other posts from Augusta University

2 min

A Snapshot of the Local Economy: Simon Medcalfe on Growth, Risk, and What Comes Next

At Augusta University’s annual Economic Forecast Breakfast hosted by the James M. Hull College of Business, Simon Medcalfe, PhD, offered a grounded, data-driven look at how the local economy is performing — and what lies ahead. Speaking to business leaders, students and community stakeholders, Medcalfe emphasized the importance of distinguishing real economic growth from inflation-driven gains, noting that while the Augusta region continues to grow, it does so at a measured pace compared to national averages. His presentation framed the local economy as stable and resilient, but not immune to broader forces shaping the U.S. outlook. A key theme of Medcalfe’s remarks was the role of research, innovation and education in sustaining long-term economic health. He pointed to strong gains in research and development across Georgia and highlighted how university-based research directly contributes to regional economic output. According to Medcalfe, investment in knowledge creation remains one of the most reliable drivers of growth, reinforcing the value of higher education institutions as economic anchors. Simon Medcalfe, PhD, is an economist with an emphasis on sports economics, social determinants of health, and the local economy. View his profile At the same time, Medcalfe cautioned against complacency. While regional fundamentals remain solid, he stressed that uncertainty at the national level continues to pose risks. “However, uncertainty abounds in national macroeconomic policy that could negatively impact growth next year,” Medcalfe said, underscoring how unresolved fiscal decisions and policy shifts can ripple down to local economies. Still, his overall outlook balanced realism with optimism. Medcalfe concluded that the Augusta region — and Georgia more broadly — is positioned to weather uncertainty thanks to diversification, investment in early education, and continued research activity. “Overall, Augusta and Georgia are positioned well for economic growth in 2026 with a strong commitment to early childhood education, a diversified labor market and strong research and development,” he said. View the full article 'Annual Economic Forecast Breakfast offers snapshot of the local economy' here: For journalists covering regional economics, workforce development, higher education, or policy-driven growth trends, Simon Medcalfe, PhD, offers clear-eyed analysis rooted in data — and an ability to translate complex economic signals into insight that matters locally. Simon is available to speak with media - simply click on his icon now to arrange an interview today.

2 min

From Libraries to Heart Health: Marlo Vernon Takes Cardiovascular Care Into Rural Georgia

Marlo Vernon, PhD, associate professor in the Department of Health Management, Economics, and Policy at Augusta University’s School of Public Health, is leading a creative public health initiative designed to improve cardiovascular monitoring in rural Georgia. Through the university’s Rural Obese At-Risk initiative, Vernon and her team are placing blood pressure monitors in local libraries, allowing residents to check them out just like books. The effort addresses a critical access gap in rural communities where preventive health tools are often limited or difficult to obtain. Vernon’s work focuses on the realities facing communities in the South’s so-called Stroke Belt, where overlapping health conditions significantly elevate cardiovascular risk. View her profile “There are significant chronic disease risk factors in this so-called Stroke Belt. We’ve got high obesity rates. We have family history. We have high rates of diabetes and kidney disease and they all kind of feed into each other to really create this cardiovascular health need in our communities. And women, in general, are just at a higher risk for this,” said Marlo Vernon, PhD. Beyond equipment access, Vernon’s research also examines how people understand and manage their health when traditional care options are limited. The library-based model helps normalize blood pressure monitoring while reducing barriers such as travel distance, cost, and limited clinic availability. It also creates opportunities to study how community-based solutions can improve awareness, engagement, and long-term cardiovascular outcomes. For journalists covering rural health, women’s health, chronic disease prevention, or innovative public-health strategies, Vernon offers grounded, real-world insight into how trusted community spaces can play a vital role in addressing persistent health disparities. A full article on this topic is available below.  To arrange an interview with Dr. Vernon simply click on her iconnow  to set up a time to talk today.

2 min

Why Insomnia May Hold the Key to Treating Depression, According to MCG Research

William Vaughn McCall, MD, professor emeritus in the Department of Psychiatry and Health Behavior at the Medical College of Georgia at Augusta University, is leading a new multi-year clinical trial aimed at addressing insomnia and depression together — two conditions that frequently occur side by side. The Assessing Improvements in Mood and Sleep (AIMS) Trial, funded by the National Institutes of Health, is exploring whether treating sleep problems through psychotherapy can also reduce lingering symptoms of depression, particularly in older adults. McCall has served as professor and Case Distinguished Chairman of the Department of Psychiatry and Health Behavior at Augusta University since 2012. His research interests include depression, electroconvulsive therapy, quality of life, insomnia, and suicide. His research has been continuously funded by the National Institute of Mental Health since 1995, and he is the author of more than 400 publications, including more than 180 peer-reviewed journal articles. View his profile McCall’s work builds on decades of research examining how disrupted sleep contributes to mood disorders. While previous studies often focused on medication-based approaches, this trial takes a different direction by testing non-pharmacological therapies that target insomnia itself. The research team, which includes collaborators from multiple universities, is evaluating whether improving sleep quality can meaningfully lower depression symptoms for patients who remain symptomatic despite antidepressant treatment. “Ultimately, the hope is to find other avenues to reduce the risk for depression and depression symptoms,” McCall says. The trial is currently recruiting adults aged 55 and older who are experiencing both insomnia and depression, with options for both in-person and remote participation. For journalists covering mental health, aging, sleep science, or emerging clinical research, McCall is a key expert offering informed perspective on how sleep-focused interventions could reshape the future of depression treatment. The full article 'New MCG trial targets insomnia and depression symptoms' is available below: And if you're interested in talking with William Vaughn McCall, MD, simply click on his icon now  to arrange a time for an interview today.

View all posts
Powered by